Thursday, February 9, 2012

Japan Ethical Drug Sales Growth Encouraging - Crecon

According to Crecon Research & Consulting, sales of ethical drugs increased 5.3% in December compared to the same month in the previous year.

Sales were driven by influenza vaccines and pneumococcus vaccines, along with steady growth in sales of DPP-4 (dipeptidyl peptidase-4) inhibitors and anticancer drugs as in the previous month.

Preliminary Report on Sales of Drugs: December 2011
 (vs December 2010)

 East JapanWest JapanTotal
Total+4.5% (+3.5%)+4.8% (+4.3%)+4.7% (+3.9%)
Ethical drugs+5.3% (+4.0%)+5.3% (+4.5%)+5.3% (+4.3%)
OTC drugs-5.4% (-5.3%)-1.8% (-0.4%)-3.7% (-3.0%)
Figures in parentheses: Cumulative sales vs corresponding period of the previous year           
(Source: Crecon Research & Consulting)